China channel feed – Endpoints News

China channel feed

With plans to bring surufatinib stateside, Chi-Med vastly scales up manufacturing with new Chinese plant

5 years ago

GlaxoSmithKline R&D vet Min Li nabs $100M to launch a Bob Nelsen-backed startup focused on China’s burgeoning neuro market

5 years ago

China opens the door for biotech investors in Hong Kong to buy Shanghai stocks, and vice versa

5 years ago

Plot thickens around Legend Biotech, GenScript with founder Frank Zhang's arrest

5 years ago

Pfizer hands LianBio $70M to tag along Perceptive's China play, with an eye to beefing up regional portfolio

5 years ago

Here's a $200M China startup idea — if you can read beyond the big words

5 years ago

Shortage of monkeys slowed down Eli Lilly's Covid-19 antibody partner. And it's a problem for everyone

5 years ago

A year after stunning China OK, Shanghai Alzheimer's drugmaker set to enroll first US patient — and the stakes are huge

5 years ago

JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China

5 years ago

Eyeing commercialization, a Shanghai-based CAR-T startup nabs a $186M megaround

5 years ago

Perceptive recruits A-list investors to back its in-house China startup with a mammoth $310M raise

5 years ago

Chinese rare disease player inks first deal around narcolepsy drug Wakix after grabbing $80M to build an ecosystem

5 years ago

The disruptors at EQRx have their eyes on the PD-(L)1 market — teeing up $150M cash to grab 2 backbone therapies from China

5 years ago

Chinese investors wager $105M on an IPO-bound biotech looking to push RNAi as mainstream cancer therapy

5 years ago

Out to pioneer gene editing in China, EdiGene bags $67M to begin clinical testing for β-thalassemia therapy, universal CAR-T

5 years ago

How hot is Hong Kong's biotech IPO market? Two biotechs just raised $800M total

5 years ago

Pfizer infuses $200M into CStone, scoring a second PD-L1 and outlining a sprawling China pact

5 years ago

SoftBank, Morningside help put US-China AI player on the map with $318M bet

5 years ago

Zai Lab hauls in $761M from Hong Kong IPO to push Zejula, more budding candidates in China — report

5 years ago

Rocked by customs investigation, Legend's CFO takes over as CEO Frank Zhang placed under house arrest

5 years ago

A 'breakthrough' PD-1? From China? FDA says why not for rare cancer

5 years ago

As China's tech giants catch onto biotech, Baidu plots $2B startup focused on diagnosis, AI drug discovery

5 years ago

AbbVie jumps into CD47 game, engineers $3B deal with ambitious Chinese player

5 years ago

Carlyle Group injects $260M into a leading cardio player in China, grabbing a seat at the deals table

5 years ago

First page Previous page 14 15 161718 19 20 Next page Last page